GENE ONLINE|News &
Opinion
Blog

Monkeypox
Ascletis Cleared By FDA To Begin Trial On Monkeypox Antiviral
2022-11-16
Second Monkeypox Death as Antiviral Enters Phase 3 Clinical Trial
2022-09-12
Monkeypox Update: New FDA Testing Guidelines as the US Passes 20,000 Cases
2022-09-08
HHS Strikes Deal With AmerisourceBergen for Expanded Monkeypox Treatment Distribution
2022-09-07
Monkeypox Cases Fall In The UK But A New Strain Of The Disease Emerges
2022-09-02
Just How Deadly is Monkeypox? Reported Death in Texas While Vaccine Production Ramps Up
2022-09-01
Growing Number of Monkeypox Tests Available to Researchers
2022-08-22
EMA Announces Advice on Switch that Could Increase The Monkeypox Vaccine Supply
2022-08-19
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Gilead Sciences Promises $5 million to Combat Monkeypox Public Health Emergency
2022-08-09
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
BD, CerTest Commercialize Research-Use Monkeypox Test Amidst Rising Cases
2022-07-29
EMA Responds to Monkeypox Public Health Emergency
2022-07-28
WHO Sounds Monkeypox Alarm as Cases Continue Rising Worldwide
2022-07-07
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top